Cargando…

Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021

BACKGROUND: This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestre, Jason, Brgdar, Ahmed, DeLisser, Horace M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798792/
https://www.ncbi.nlm.nih.gov/pubmed/36533616
http://dx.doi.org/10.1161/JAHA.122.028237
_version_ 1784860980240449536
author Silvestre, Jason
Brgdar, Ahmed
DeLisser, Horace M.
author_facet Silvestre, Jason
Brgdar, Ahmed
DeLisser, Horace M.
author_sort Silvestre, Jason
collection PubMed
description BACKGROUND: This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 ranked fellowship choices. METHODS AND RESULTS: This was a retrospective cohort study of all applicants in the Cardiovascular Disease Fellowship Match from 2010 to 2021 (n=14 674). Chi‐square tests were used to compare trends over time and match rates by applicant archetype (US allopathic graduates and non‐US allopathic graduates). The annual number of applicants increased from 1184 to 1575 (33% increase) while training positions increased 718 to 1045 (46% increase) over the study period. The percentage of applicants that matched increased from 61% in 2010 to 66% in 2021 (P=0.090). The average match rate was 70% over the study period. During each year, US allopathic graduates had higher match rates than non‐US allopathic graduates (P<0.001), but this disparity narrowed with time (83% versus 41% in 2010 and 83% versus 54% in 2021). Most applicants matched at 1 of their top 3 choices (first, 37%; second, 12%; third, 7%). Applicants matching at 1 of their top 3 choices decreased from 51% in 2010 to 48% in 2021 (P=0.704). CONCLUSIONS: The Cardiovascular Disease Fellowship Match has remained equally competitive over the past decade. US allopathic graduates have an advantage over non‐US allopathic graduates. Most applicants match at 1 of their top 3 ranked fellowship choices.
format Online
Article
Text
id pubmed-9798792
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97987922023-01-05 Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021 Silvestre, Jason Brgdar, Ahmed DeLisser, Horace M. J Am Heart Assoc Brief Communication BACKGROUND: This study elucidates recent trends in application and match rates in the Cardiovascular Disease Fellowship Match. We hypothesized that (1) match rates have increased with time; (2) match rates are highest for US allopathic graduates; and (3) most candidates match at 1 of their top 3 ranked fellowship choices. METHODS AND RESULTS: This was a retrospective cohort study of all applicants in the Cardiovascular Disease Fellowship Match from 2010 to 2021 (n=14 674). Chi‐square tests were used to compare trends over time and match rates by applicant archetype (US allopathic graduates and non‐US allopathic graduates). The annual number of applicants increased from 1184 to 1575 (33% increase) while training positions increased 718 to 1045 (46% increase) over the study period. The percentage of applicants that matched increased from 61% in 2010 to 66% in 2021 (P=0.090). The average match rate was 70% over the study period. During each year, US allopathic graduates had higher match rates than non‐US allopathic graduates (P<0.001), but this disparity narrowed with time (83% versus 41% in 2010 and 83% versus 54% in 2021). Most applicants matched at 1 of their top 3 choices (first, 37%; second, 12%; third, 7%). Applicants matching at 1 of their top 3 choices decreased from 51% in 2010 to 48% in 2021 (P=0.704). CONCLUSIONS: The Cardiovascular Disease Fellowship Match has remained equally competitive over the past decade. US allopathic graduates have an advantage over non‐US allopathic graduates. Most applicants match at 1 of their top 3 ranked fellowship choices. John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC9798792/ /pubmed/36533616 http://dx.doi.org/10.1161/JAHA.122.028237 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Brief Communication
Silvestre, Jason
Brgdar, Ahmed
DeLisser, Horace M.
Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_full Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_fullStr Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_full_unstemmed Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_short Match Outcomes for Cardiovascular Disease Fellowship Training: 2010 to 2021
title_sort match outcomes for cardiovascular disease fellowship training: 2010 to 2021
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798792/
https://www.ncbi.nlm.nih.gov/pubmed/36533616
http://dx.doi.org/10.1161/JAHA.122.028237
work_keys_str_mv AT silvestrejason matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021
AT brgdarahmed matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021
AT delisserhoracem matchoutcomesforcardiovasculardiseasefellowshiptraining2010to2021